303 related articles for article (PubMed ID: 26847701)
1. KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway.
Li L; Duan T; Wang X; Zhang RH; Zhang M; Wang S; Wang F; Wu Y; Huang H; Kang T
Sci Rep; 2016 Feb; 6():20460. PubMed ID: 26847701
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
[TBL] [Abstract][Full Text] [Related]
4. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
5. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
7. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
[TBL] [Abstract][Full Text] [Related]
9. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
10. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
[TBL] [Abstract][Full Text] [Related]
11. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
[TBL] [Abstract][Full Text] [Related]
13. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
[TBL] [Abstract][Full Text] [Related]
14. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
15. Contribution of KCTD12 to esophageal squamous cell carcinoma.
Abbaszadegan MR; Taghehchian N; Li L; Aarabi A; Moghbeli M
BMC Cancer; 2018 Aug; 18(1):853. PubMed ID: 30157793
[TBL] [Abstract][Full Text] [Related]
16. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
18. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
[TBL] [Abstract][Full Text] [Related]
19. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
Wei F; Zhang T; Yang Z; Wei JC; Shen HF; Xiao D; Wang Q; Yang P; Chen HC; Hu H; Chen ZP; Huang Q; Li WL; Cao J
Cell Physiol Biochem; 2018; 46(2):829-846. PubMed ID: 29627822
[TBL] [Abstract][Full Text] [Related]
20. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
